HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David Cibula Selected Research

S-1,2-dichlorovinyl-N-acetylcysteine

1/2022An Autologous Dendritic Cell Vaccine Promotes Anticancer Immunity in Patients with Ovarian Cancer with Low Mutational Burden and Cold Tumors.
1/2022Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial.
1/2021Dendritic cell-based immunotherapy (DCVAC/OvCa) combined with second-line chemotherapy in platinum-sensitive ovarian cancer (SOV02): A randomized, open-label, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David Cibula Research Topics

Disease

40Neoplasms (Cancer)
06/2022 - 01/2008
31Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 11/2008
24Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 02/2011
11Endometrial Neoplasms (Endometrial Cancer)
01/2022 - 11/2013
8Ovarian Epithelial Carcinoma
01/2022 - 01/2012
6Carcinoma (Carcinomatosis)
01/2022 - 01/2011
5Breast Neoplasms (Breast Cancer)
01/2022 - 02/2007
5Lymphocele
03/2019 - 03/2014
4Adenocarcinoma
01/2022 - 03/2015
4Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal)
01/2009 - 01/2004
3Neoplasm Metastasis (Metastasis)
11/2021 - 01/2010
3Disease Progression
10/2021 - 01/2015
3Insulin Resistance
09/2008 - 01/2004
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 03/2015
2Neoplasm Micrometastasis
11/2021 - 01/2020
2Margins of Excision
01/2020 - 11/2009
2Hirsutism
06/2009 - 03/2008
2Acne Vulgaris
06/2009 - 03/2008
1Adenosquamous Carcinoma
01/2022
1Heart Diseases (Heart Disease)
01/2022
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2022
1Vulvar Neoplasms (Vulvar Cancer)
11/2021
1Carcinogenesis
03/2021
1Septic Shock (Toxic Shock Syndrome)
01/2021
1Infertility (Sterility)
01/2020
1Spontaneous Abortion (Miscarriage)
01/2020
1Rupture
01/2020
1Bacteriuria
01/2020
1Inflammation (Inflammations)
01/2019
1Circulating Neoplastic Cells
12/2017
1Endometriosis
12/2017

Drug/Important Bio-Agent (IBA)

8PlatinumIBA
10/2021 - 02/2011
7DNA (Deoxyribonucleic Acid)IBA
01/2022 - 05/2009
6Biomarkers (Surrogate Marker)IBA
01/2022 - 02/2012
4Paclitaxel (Taxol)FDA LinkGeneric
01/2022 - 01/2015
4Carboplatin (JM8)FDA LinkGeneric
01/2022 - 01/2015
3Hormones (Hormone)IBA
06/2022 - 03/2015
3S-1,2-dichlorovinyl-N-acetylcysteineIBA
01/2022 - 01/2021
3Immune Checkpoint InhibitorsIBA
01/2022 - 10/2021
3Glucose (Dextrose)FDA LinkGeneric
01/2009 - 01/2004
2A-Form DNA (A-DNA)IBA
01/2022 - 01/2014
2ProgesteroneFDA LinkGeneric
01/2022 - 06/2005
2Progesterone Receptors (Progesterone Receptor)IBA
01/2022 - 03/2015
2GemcitabineFDA Link
01/2021 - 12/2017
2olaparibIBA
10/2020 - 01/2015
2CollagenIBA
01/2018 - 08/2014
2FibrinIBA
01/2018 - 08/2014
2Cell-Free Nucleic AcidsIBA
12/2017 - 12/2017
2Transcription Factors (Transcription Factor)IBA
07/2016 - 11/2013
2Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2015 - 01/2015
2AntigensIBA
04/2013 - 01/2012
2S100 Proteins (S 100 Protein)IBA
04/2012 - 12/2010
2SynaptophysinIBA
12/2010 - 01/2008
2Sex Hormone-Binding GlobulinIBA
06/2009 - 04/2007
2AndrogensIBA
06/2009 - 03/2008
1rucaparibIBA
01/2022
1Antineoplastic Agents (Antineoplastics)IBA
01/2022
1Indicators and Reagents (Reagents)IBA
01/2022
1Poly Adenosine Diphosphate RiboseIBA
01/2022
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
01/2022
1Poly I-CIBA
01/2022
1VaccinesIBA
01/2022
1niraparibIBA
10/2021
1dostarlimabIBA
10/2021
1Hepatocyte Nuclear FactorsIBA
03/2021
1Bevacizumab (Avastin)FDA Link
01/2021
14- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA
01/2021
1tisotumab vedotinIBA
01/2021
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2020
1binimetinibIBA
11/2020
1TabletsIBA
10/2020
1liposomal doxorubicin (Doxil)FDA Link
10/2020
1glycoprotein CX 1IBA
01/2020
1Fibronectins (Fibronectin)IBA
01/2020
1nintedanibIBA
01/2020
1Suppositories (Vaginal Suppositories)IBA
01/2019
1Circulating Tumor DNAIBA
12/2017
1Diphosphonates (Bisphosphonates)IBA
12/2017
1hydrogen sulfite (bisulfite)IBA
12/2017

Therapy/Procedure

23Lymph Node Excision (Lymph Node Dissection)
01/2022 - 01/2011
18Hysterectomy
01/2022 - 11/2009
14Drug Therapy (Chemotherapy)
01/2022 - 01/2012
13Radiotherapy
11/2021 - 03/2014
8Trachelectomy
01/2022 - 11/2008
6Therapeutics
01/2021 - 06/2005
4Cytoreduction Surgical Procedures
01/2019 - 02/2011
4Neoadjuvant Therapy
01/2019 - 01/2016
3Minimally Invasive Surgical Procedures
01/2022 - 01/2020
3Palliative Care (Palliative Therapy)
02/2021 - 01/2021
3Salpingo-oophorectomy
12/2020 - 08/2011
2Immunotherapy
01/2022 - 01/2021
2Brachytherapy
12/2020 - 10/2020
2Adjuvant Radiotherapy
01/2020 - 12/2018
2Tubal Sterilization (Tubal Ligation)
01/2019 - 06/2011
1Conservative Treatment
01/2022
1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2022
1Retreatment
10/2021
1Colpotomy
01/2020
1Cervical Cerclage
01/2020
1Adjuvant Chemotherapy
12/2017